Site Search
Search Results
Marylanders to Gain Access to Biomarker Testing on Jan. 1
ANNAPOLIS, MD – DECEMBER 20, 2023 – On January 1, 2024, Marylanders will gain access to biomarker testing when Chapter 322 of the Laws of 2023 takes effect for private insurers. The legislation, which requires coverage of biomarker testing when supported by scientific and medical evidence, received near-unanimous support in the Senate and House of Delegates. Governor ...
Maryland Lawmakers Overwhelmingly Support Increasing Access to Biomarker Testing
... passage in the Senate and House of Delegates and representing a victory for cancer patients across Maryland. The legislation aims to ensure biomarker testing is covered by all state-regulated health plans, including Medicaid, when it is supported by medical and scientific evidence. With the Governor’s signature, more Marylanders will benefit from biomarker testing, a critical step in accessing precision medicine services. Dubbed ‘the right treatment at the right time,’ precision medicine ...
Gov. Moore Approves Legislation to Expand Access to Biomarker Testing
... Gov. Wes Moore will be signing HB 1217 / SB 805—among many other bills—into law. This legislation will increase insurance coverage for biomarker testing, making this form of precision medicine available to more Marylanders. The signing ceremony will take place today at 12:00pm in the State ... champions who saw HB 1217 / SB 805 to the finish line. For more information on precision medicine, cancer biomarkers, current barriers to biomarker testing and ACS CAN’s policy recommendations, visit: www.fightcancer.org/biomarkers . ### About ACS CAN The American Cancer Society ...
Maryland Biomarkers 101 Educational Forum
... 101 Educational Forum on October 28, 2021 from 9:00am – 10:00am virtually. Focus of the forum This event will explore the impact of biomarker testing and biomarker-driven therapies on cancer treatment and outcomes, and examine the barriers patients face in accessing guideline-indicated biomarker ...
2023 Maryland Legislative Priorities
... products. We will be making the following fact-based policies a priority and ask for your support: Ensuring Access to Quality Care Access to Biomarker Testing: ACS CAN will advocate for improved coverage of comprehensive biomarker testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a ...
Maryland State Budget Produces Mixed Results in Fight against Cancer
... in the fight against cancer. While the state made sound investments in cancer research and protected Medicaid recipients’ ability to access biomarker testing, it missed an opportunity to save the lives and lungs of Maryland’s youth by cutting funding for the state’s tobacco prevention and ... in our state. “We’re thankful that lawmakers did not accept the recommendation to delay patients insured through Medicaid access to biomarker testing. Back in 2023, the General Assembly passed legislation to extend coverage for biomarker testing, connecting more patients to the ...
2023 Maryland Legislative Session Summary
... Action Network (ACS CAN) worked with the Maryland General Assembly in support of the following priorities: Ensuring Access to Quality Care · Biomarker Testing Coverage: Biomarker insurance coverage legislation passed both houses and is awaiting delivery to the Governor. The bill provides full coverage (not just ...
2022 Maryland General Assembly Session Summary
... program established under Chapter 621 of 2018. The bill was signed into law by Governor Hogan will take effect on January 1, 2023. Access to Biomarker Testing: ACS CAN prioritized the education of policymakers about the role of biomarker testing in precision medicine. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses ...